NCT00946751View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Seizure
Interventions
DRUG

Levetiracetam Tablets, 750 mg (Sandoz Inc.)

DRUG

Keppra (Levetiracetam) Tablets, 750 mg (UCB Pharma, Inc)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00946751 - To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions | Biotech Hunter | Biotech Hunter